MINIjectTM, iSTAR Medical’s minimally invasive glaucoma surgery (MIGS) device, has been presented as part of the ‘Emerging Technologies’ session at the prestigious 2020 virtual Interventional Glaucoma Congress (IGC) meeting. Dr Paul Singh, who presented iSTAR Medical’s technology, is a glaucoma specialist, President of The Eye Centers of Racine & Kenosha (Wisconsin, USA) and one of the implanting surgeons in MINIject trials.
MINIject is able to maintain significant intraocular pressure reduction in the longer-term, with a reassuring safety profile, thanks to its innovative bio-integration and anti-inflammatory properties.
, he explained.
The results seen so far in over 130 patients are certainly promising, particularly considering these results are achieved in a standalone procedure.
, he added.
The IGC meeting is an invitation-only, think tank–style meeting for glaucoma specialists to exchange ideas on innovations and advanced practices for improved patient care. It is chaired by glaucoma specialists Doctors Ike Ahmed, Rick Lewis, and Arsham Sheybani.
